"Zeranol"

Effects of increasing dosages of zeranol implants on lamb growth, carcass characteristics, blood hormones, and nitrogen metabolism. The objective of this research was to compare the growth performance, incidence of prolapse and mortality, carcass characteristics, blood hormone concentration, and N balance of lambs implanted with increasing dosages of zeranol. One hundred forty-four crossbred lambs (29.6 ± 4.9 kg) were used in a completely random design and placed into 16 feedlot pens (4 pens/treatment) for a 116 d finishing study. Lambs were fed an 84.7% corn and 15.3% market lamb pellet (DM basis) diet ad libitum. Treatments were 0, 12, 24, and 36 mg zeranol (Ralgro; Schering-Plough), and lambs were implanted in the ear according to treatment on d 0. Lambs were weighed. Thirty lambs

backgrounding study. Heifers were received approximately 60 d prior to study initiation. Initial processing (53 d before study initiation) included individual BW, application of an identification tag, vaccination against viral respiratory pathogens and clostridial species, and administration of doramectin pour-on for control of internal and external parasites. All heifers were administered 36 mg of zeranol

, and cow parity and randomly assigned to receive no implant (NOIP) or 36 mg of zeranol on d -14, 0, or 14, relative to weaning (IP-14, IP0, and IP+14, respectively; 12 steers/treatment). From d -14 to 0, cow-calf pairs remained on a single, tall-fescue pasture with no access to concentrate supplementation. Steers were weaned on d 0, stratified by treatment and BW, and then allocated into 1 of 16 drylot ). On d 252, BW was greater for IP-14 and IP0 than NOIP steers ( ≤ 0.05) and intermediate for IP+14 steers, but ADG and G:F from d 57 to 252 and carcass characteristics at slaughter did not differ among treatments ( ≥ 0.16). Thus, the 36-mg zeranol implant did not elicit an inflammatory response or affect the overall vaccine response of steers (except for IBRV titers). However, growth of steers during

synthetic estrogen mimics [zeranol (α-ZAL) and zearalanone (ZAN)] by maize seedlings. Growing whole maize seedlings in hydroponic solutions of target estrogens resulted in both oxidative (i.e., 17β-E2 to E1 and α-ZAL to ZAN) and reductive (i.e., E1 to 17β-E2 and ZAN to α-ZAL) transformations. Although all four estrogens accumulated in maize roots as both parents and products, the shoots contained only 17β

athlete from inadvertent doping. Within the past few years several sources of inadvertent doping with anabolic agents have been identified. Among these are nutritional supplements adulterated with AAS, meat products contaminated with clenbuterol, mycotoxin (zearalenone) contamination leading to zeranol findings, and natural products containing endogenous AAS. The protection strategy consists of further

Phototransformation rates and mechanisms for synthetic hormone growth promoters used in animal agriculture. Trenbolone acetate, melengestrol acetate, and zeranol are synthetic hormones extensively used as growth promoters in animal agriculture, yet despite occurrence in water and soil little is known about their environmental fate. Here, we establish the time scales and mechanisms by which to solution variables (e.g., pH, temperature, and cosolutes). Direct photolysis yielded products that not only are more photostable but also maintain their steroidal ring structure and therefore may retain some biological activity. In contrast, zeranol, β-zearalanol, and zearalanone only exhibited reactivity in irradiated solutions of model humic and fulvic acids, and rates of indirect photolysis increased

Mineral and nitrogen balance in lambs implanted with zeranol. Fourteen crossbred wether lambs (average BW, 28 kg +/- 2.3) were either implanted (12 mg of zeranol) or not implanted and group-fed an 86% concentrate diet for 21 d. Lambs were then moved to metabolism stalls and fed .8 kg/d for a 10-d stall adjustment followed by a 7-d total collection of feces and urine. Feed, feces and urine were analyzed for Ca, P, Mg, Zn, Mn, Cu, and N. Apparent absorption of Mn, Cu, and N, were similar for implanted and nonimplanted lambs. Zeranol did not affect (P > .10) the retention of Mn or Cu. Zeranol decreased fecal excretion of CA 22% (P < .01), P 27% (P < .05), Mg 11% (P < .03) and Zn 9% (P < .10). This increased apparent absorption of CA 88% (P < .01), P 193% ( P < .05), Mg 9% (P < .05) and Zn 45% (P

Influence of frame size and zeranol on growth, compositional growth and plasma hormone characteristics. A 2 X 2 factorially arranged trial was conducted to compare effects of implant (zeranol) and frame size on weight and compositional gain, and plasma hormone concentrations. Angus, Charolais X Hereford and Hereford X Angus yearling steers (34 steers averaging 270 kg body weight) were randomly . Implant did not influence (P greater than .10) plasma T3, T4 and glucose concentrations regardless of frame size. Steers responded differently to zeranol implant over time regarding plasma T4 concentrations (P less than .003). Steers differing in frame size responded similarly in rate of gain, in feed conversion and in patterns of plasma insulin concentrations to zeranol implants.

) body weight of 377.0 (+/- 37) kg. Steers were implanted with zeranol and alternately separated to fill each of 24 pens. Groups of steers within 12 matched pairs of pens were randomly allocated to treatment with doramectin or no treatment with doramectin for internal nematodes. Fecal samples were collected from approximately every twentieth steer from each pen at day 0 and at reimplant (approx day 60

The effect of estradiol, trenbolone acetate, or zeranol on growth rate, mammary development, carcass traits, and plasma estradiol concentrations of beef heifers. The effect of a single implantation (on d 1) with one or two long-acting, biodegradable estradiol implants (1E or 2E) on plasma estradiol concentrations in beef heifers was determined. The growth rates of these (2E) heifers , and of heifers repeatedly implanted with trenbolone acetate (TBA) or zeranol (Z) on d 1, 84, 168, and 252 of the trial, were compared to growth rates of controls. Trenbolone acetate alone was compared to TBA + 2E, and 2E was compared to 1E. At a mean age of 84 d (d 1 of experiment), 81 Hereford x Friesian heifers were allocated at random to the following treatments: Control (n = 15); TBA (n = 15); 1E (n = 12

* Zeranol * Zearalenone Plant

* Zeranol * Zearalenone Plant

Occupational exposure to zeranol, an animal growth promoter. Zeranol (3,4,5,6,7,8,9,10,11,12-Decahydro-7,14,16-trihydroxy-3-methyl-1H-2 - benzoxacyclotetradecin-1-one) is a synthetic oestrogenic agent used as an animal growth promoter. The effects of occupational exposure to zeranol in 11 exposed workers from a pelletising plant and 14 nonexposed subjects were assessed. A questionnaire showed that more breast symptoms were reported by male and female plant workers compared with non-exposed subjects, although the difference was not statistically significant. Clinical assessment showed no cases of gynaecomastia in all the male participants. Blood samples analysed by high performance liquid chromatography for zeranol, its precursor zearalenone, and its main metabolites did not show any

Effects of in utero exposure to nonsteroidal estrogens on mouse testis. Male mice exposed in utero to alpha-zearalanol (zeranol) or diethylstilbestrol (DES) were analyzed postnatally to evaluate the possible changes on their testicular morphology as part of an examination of the effects of transplacental exposure to non-steroidal estrogens on sensitive tissues. Pregnant NMRI mice were injected subcutaneously with ethyl oleate (0.1 mL) alone (negative control) or with 150 micrograms/kg of body weight of zeranol or DES (positive control) on days 9 and 10 of gestation. Experimental and control male offspring were euthanized at days 45 (n = 47), 90 (n = 44), 180 (n = 40) and 365 (n = 26) after birth and their gonads were examined by light and electron microscopy. The results suggested that prenatal

Development and evaluation of immunoassay for zeranol in bovine urine A high affinity polyclonal antibody-based enzyme linked immunosorbent assay (ELISA) was developed for the quantification of zeranol in bovine urine. On the basis of urine matrix studies, the optimized dilution factors producing insignificant matrix interference were selected as 1:5 in pretreatment. In the improved ELISA , the linear response range was between 0.02 and 1 microg/ml, and the detection limit was 0.02 microg/ml for the assay. The overall recoveries and the coefficients of variation (CVs) were in the range of 82% to approximately 127% and 3.5% to approximately 8.8%, respectively. Thirty-six bovine urine samples spiked with zeranol (ranging from 0.2 to 10 microg/ml) were detected by the ELISA and liquid

with zeranol (Ralgro) were compared with 30 spayed heifers implanted with Synovex-S. The data were analyzed as a one-way analysis of variance. The ADG for spayed heifers on Ralgro did not differ significantly (p>0.05) from those implanted with Synovex-S over a period of 92 days, suggesting that both implants produce similar growth responses.

Transcriptional regulation of pituitary synthesis and secretion of growth hormone in growing wethers and the influence of zeranol on these mechanisms. This experiment evaluated relationships between pituitary messenger RNA levels of the transcription factor Pit-1, the growth hormone releasing-hormone receptor (GHRHR), and synthesis and secretion of GH in growing wethers. The experiment also evaluated the influence of the estrogenic compound, zeranol, on these relationships. Seventy wethers that were 9.5 +/- 1 day of age were randomly assigned to a control group or to one of three zeranol treatment groups that were implanted (12 mg, Ralgro) at 0, 45, and (or) 90 days of age. Twenty-eight days after implantation (i.e., Days 28, 73, 118) and on Day 135, sera were collected serially from wethers

Effect of zeranol or melengestrol acetate (MGA) on testicular and antler development and aggression in farmed fallow bucks. Fifteen yearling fallow bucks were randomly assigned by BW to one of three treatment groups: control (C; n = 5), melengestrol acetate (MGA; n = 5), and zeranol (Z; n = 5), to evaluate effects on testicular development, aggressive behavior, antler growth, sexual activity, ADG , and BW. Zeranol-treated bucks received zeranol ear implants (36 mg) at 90-d intervals, and MGA-treated bucks received MGA in the ration (100 microg x animal(-1) x d(-1)). Bucks grazed ryegrass/Coastal bermudagrass pasture and were supplemented with 3:1 corn/soybean meal at 0.45 kg x animal(-1) x d(-1). Body weights, body condition scores (BCS), blood samples, and testis measurements were obtained at d

Body composition, leptin, and the leptin receptor and their relationship to the growth hormone (GH) axis in growing wethers treated with zeranol. Age-related changes in body composition, leptin, and hypothalamic-pituitary expression of the leptin receptor and associative relationships of these factors to constituents of the growth hormone (GH) axis were evaluated. Seventy wethers were randomly assigned at birth to one of four treatment groups: control; treatment 1 implanted with the estrogenic compound zeranol (12 mg, Ralgro on days 0, 45, and 90; treatment 2 received zeranol on days 45 and 90; and treatment 3 received zeranol on day 90. Serum and tissues were collected from wethers (n > or = 5) from each group on days 28, 73, 118, and 135. Percent body fat and leptin increased linearly (P

Implanting young bulls with zeranol from birth to four slaughter ages: I. Live measurements, behavior, masculinity and carcass characteristics. Seventy-two Simmental bull calves were allotted randomly at birth to either a zeranol (Ralgro) implanted (I) treatment or a nonimplanted control (C) group. At birth, bulls assigned to the I treatment were implanted with 36 mg of zeranol and reimplanted , 13.8 and 15.7 mo, but similar (P greater than .10) to C bulls at 17.4 mo. Growth traits (all weights plus hide and femur measurements) and maturation traits (skeletal and lean maturities, marbling scores, fat thicknesses and pizzle eye sizes) increased the most from 12.0 to 13.8 mo and 13.8 to 15.7 mo, respectively. We concluded that implanting young bulls with zeranol from birth to slaughter had